StockrabitBrowse analysts
Analyst questions

Avneesh Barman

Vaikarya
PPLPHARMA

Piramal Pharma Limited

All company calls
Piramal Pharma Limited CC-Sep25.pdf
6 Nov 2025
Open call
  1. Can you give some color on the base CDMO growth? Just like, I mean, in the first quarter, there was a disclosure that the base CDMO growth grew by mid -teen. Can you give a similar color for this quarter?

    Read in transcript
  2. My second question is on the U.S. administration and the intent. Do you think whatever has been happening by the Trump administration, in your view, what are the chances of moving API manufacturing either from India or China in terms of API or let's say from Ireland in terms of formulation? How do you see that moving back to the U.S.? Is that feasible, probable? I mean, whatever you can tell about it.

    Read in transcript
  3. This was helpful, Peter. I will get back.

    Read in transcript